Zeliang Ma
Overview
Explore the profile of Zeliang Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Men Y, Yang X, Sun S, Bao Y, Ma Z, et al.
Radiat Oncol
. 2025 Mar;
20(1):38.
PMID: 40082994
Background: The ADAURA study indicated that adjuvant TKI therapy improves survival in postoperative patients with EGFR-mutated (EGFRm) non-small-cell lung cancer (NSCLC), especially in stage III disease. However, the effect of...
2.
Ma Z, Liu Y, Bao Y, Wang M, Yang X, Men Y, et al.
Lung Cancer
. 2024 Dec;
199:108063.
PMID: 39700682
Purpose: The therapeutic advantage of postoperative radiation therapy (PORT) for non-small cell lung cancer (NSCLC) has not been shown to benefit overall survival (OS) according to two randomized controlled trials...
3.
Hu Z, Yang Z, Fu Z, Fu Y, Ma Z, Zhou Z, et al.
Front Immunol
. 2024 Dec;
15:1472870.
PMID: 39628474
Background: The relative superiority of atezolizumab-bevacizumab versus pembrolizumab-lenvatinib in treatment of unresectable hepatocellular carcinoma (HCC) remains uncertain. This study aims to compare the efficacy of atezolizumab-bevacizumab and pembrolizumab-lenvatinib in first-line...
4.
Liu Y, Wang Y, Hu X, Wang X, Xue L, Pang Q, et al.
Insights Imaging
. 2024 Nov;
15(1):277.
PMID: 39546168
Objectives: This study aimed to develop and validate a deep-learning radiomics model using CT, T2, and DWI images for predicting pathological complete response (pCR) in patients with esophageal squamous cell...
5.
Miao C, Chen Y, Zhang H, Zhao W, Wang C, Ma Z, et al.
Front Immunol
. 2024 Nov;
15:1464728.
PMID: 39483483
Background: The shaping of the tumor immune microenvironment does not only rely on tumor-infiltrating lymphocytes but on the recruitment of lymphocytes in peripheral blood. Monitoring peripheral blood lymphocyte subsets level...
6.
Yousufuddin M, Ma Z, Barkoudah E, Tahir M, Issa M, Wang Z, et al.
Eur J Intern Med
. 2024 Oct;
131:71-82.
PMID: 39438195
Background: Optimal systolic blood pressure (SBP) targets for the treatment of hospitalized acute decompensated heart failure (ADHF) patients are not known. Objectives: To investigate the association between SBP <130 mmHg...
7.
Ma Z, Liu Y, Bao Y, Liu Q, Yang X, Men Y, et al.
BMC Cancer
. 2024 Aug;
24(1):968.
PMID: 39112971
Introduction: The estimated dose of radiation to immune cells (EDRIC) has been shown to correlate with the overall survival (OS) of patients who receive definitive thoracic radiotherapy. However, the planning...
8.
Liu Y, Ma Z, Bao Y, Wang X, Men Y, Sun X, et al.
Heliyon
. 2024 Jul;
10(13):e33702.
PMID: 39050414
Purpose: We aimed to integrate MR radiomics and dynamic hematological factors to build a model to predict pathological complete response (pCR) to neoadjuvant chemoradiotherapy (NCRT) in esophageal squamous cell carcinoma...
9.
Miao C, Chen Y, Zhang H, Zhao W, Wang C, Ma Z, et al.
Transl Lung Cancer Res
. 2024 Jul;
13(6):1264-1276.
PMID: 38973958
Background: Immune checkpoint inhibitor (ICI) has become pivotal in the treatment of advanced lung cancer, yet the absence of reliable biomarkers for assessing treatment response poses a significant challenge. This...
10.
Ma Z, Liu Q, Hui Z
Int J Radiat Oncol Biol Phys
. 2024 Jun;
119(3):1023.
PMID: 38851257
No abstract available.